Search

Search Constraints

You searched for: Record Type Journal Article Author/Creator Cooper, Z.A.

Search Results

1. 160P COLUMBIA-1: A phase Ib/II, open-label, randomized, multicenter study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab as first-line (1L) therapy in metastatic microsatellite-stable colorectal cancer (MSS-mCRC). (December 2022)

2. 188P IPH5201 as monotherapy or in combination with durvalumab (D) in advanced solid tumours. (December 2022)

3. 190P Combination of IPH5201, a blocking antibody targeting the CD39 immunosuppressive pathway, with durvalumab and chemotherapies: Preclinical rationale. (December 2022)